Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IceCure Medical (ICCM) Current Deferred Revenue (2022 - 2024)

Historic Current Deferred Revenue for IceCure Medical (ICCM) over the last 3 years, with Q4 2024 value amounting to $334000.0.

  • IceCure Medical's Current Deferred Revenue rose 7860.96% to $334000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $334000.0, marking a year-over-year increase of 7860.96%. This contributed to the annual value of $334000.0 for FY2024, which is 7860.96% up from last year.
  • IceCure Medical's Current Deferred Revenue amounted to $334000.0 in Q4 2024, which was up 7860.96% from $187000.0 recorded in Q4 2023.
  • IceCure Medical's Current Deferred Revenue's 5-year high stood at $646000.0 during Q4 2022, with a 5-year trough of $187000.0 in Q4 2023.
  • Moreover, its 3-year median value for Current Deferred Revenue was $334000.0 (2024), whereas its average is $389000.0.
  • Its Current Deferred Revenue has fluctuated over the past 5 years, first crashed by 7105.26% in 2023, then surged by 7860.96% in 2024.
  • Over the past 3 years, IceCure Medical's Current Deferred Revenue (Quarter) stood at $646000.0 in 2022, then plummeted by 71.05% to $187000.0 in 2023, then soared by 78.61% to $334000.0 in 2024.
  • Its Current Deferred Revenue stands at $334000.0 for Q4 2024, versus $187000.0 for Q4 2023 and $646000.0 for Q4 2022.